Product image of Imikeraderm (Imiquimod) supplied by GNH India

Imikeraderm

Active Ingredient:
Imiquimod
Origin:
EU

Imikeraderm (Imiquimod)

Imiquimod, the active ingredient in Imikeraderm, is a immune response modifier presented as a topical formulation for skin use. It is applied to the skin to treat precancerous lesions and certain viral warts by stimulating a local immune response.

GNH India supplies Imikeraderm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Dermapharm Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

Imiquimod is a topical immunomodulator used to treat viral or precancerous skin lesions.

  • Actinic keratosis: clears precancerous lesions on sun‑damaged skin.
  • Superficial basal cell carcinoma: promotes tumor regression in early‑stage basal cell carcinoma.
  • External genital warts (condyloma acuminata): induces immune‑mediated clearance of HPV‑related warts.

How It Works

  • Imiquimod acts as a Toll‑like receptor 7 (TLR7) agonist on dendritic cells and macrophages, triggering the release of cytokines such as interferon‑α, interleukin‑12 and tumor necrosis factor‑α. This cytokine cascade activates both innate and adaptive immune pathways, leading to antiviral activity and antitumor effects at the site of application.

Side Effects

Local and systemic reactions may occur with topical use of imiquimod.

Common Side Effects

  • Erythema: redness at the application site.
  • Itching: mild to moderate pruritus.
  • Burning sensation: transient heat or stinging.
  • Pain: discomfort during treatment.
  • Swelling: localized edema.
  • Crusting or scaling: skin flaking.

Serious or Rare Side Effects

  • Severe allergic reaction: angioedema or anaphylaxis.
  • Stevens‑Johnson syndrome: extensive skin detachment.
  • Widespread ulceration: deep skin breakdown beyond treated area.
  • Systemic infection: secondary bacterial infection of lesions.
  • Persistent pigment changes: long‑lasting hyper‑ or hypopigmentation.
  • Lymphadenopathy: swollen regional lymph nodes.

Precautions & Warnings

Imiquimod should be used with caution and under medical supervision.

  • Hypersensitivity: discontinue if allergic reaction occurs.
  • Broken skin: avoid application on open wounds or abrasions.
  • Immunocompromised patients: monitor closely for excessive irritation.
  • Pregnancy and lactation: use only if potential benefit justifies potential risk.
  • Concomitant topical steroids: may reduce efficacy, assess need.
  • Store below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Imiquimod may interact with other medications that affect immune function.

Major Interactions (Avoid)

  • Systemic corticosteroids: may suppress intended immune response.
  • Biologic immunosuppressants (e.g., TNF‑α inhibitors): reduce efficacy and increase infection risk.
  • Chemotherapy agents: heightened local toxicity.
  • Live vaccines: potential for altered vaccine response.
  • Other topical immune modulators: risk of excessive inflammation.

Moderate Interactions (Monitor Closely)

  • Topical corticosteroids: may diminish therapeutic effect.
  • Retinoids (topical or oral): increase skin irritation.
  • Phototherapy: additive photosensitivity.
  • Antihistamines: may mask early signs of severe reaction.
  • Antifungal creams: possible formulation incompatibility.

Frequently Asked Questions

Imikeraderm contains imiquimod, a topical immunomodulator indicated for the treatment of actinic keratosis, superficial basal cell carcinoma, and external genital warts. It works by stimulating the local immune system to clear precancerous lesions and virus‑related warts.

Imiquimod activates Toll‑like receptor 7 on immune cells in the skin, leading to the production of cytokines such as interferon‑α, interleukin‑12 and tumor necrosis factor‑α. This immune activation promotes antiviral activity and antitumor effects, helping to eliminate abnormal cells.

The dosing schedule for Imikeraderm is determined by the prescribing clinician based on the specific indication, lesion size, and patient factors. The prescriber will provide detailed instructions on frequency, duration, and amount of product to apply.

Safety of imiquimod in pregnancy or while breastfeeding has not been fully established. It should be used only if the potential benefit outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To order Imikeraderm, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details and import documentation.

Imikeraderm offers a non‑surgical, topical option that harnesses the immune system, whereas alternatives may include surgical excision, cryotherapy, or other topical agents like 5‑fluorouracil. Imiquimod’s mechanism can provide lesion clearance with minimal scarring, but treatment duration may be longer.

Imikeraderm should be stored below 25 °C in its original container, protected from moisture and direct sunlight. Keep the product out of reach of children and do not use if the packaging is damaged.

Imikeraderm is applied topically to clean, dry skin in a thin layer, as directed by the prescriber. The treated area is usually covered with a dressing if recommended, and the product is left on for the prescribed period before washing off.

Serious risks include severe allergic reactions, Stevens‑Johnson syndrome, extensive ulceration, and secondary bacterial infections. Patients should seek immediate medical attention if they experience widespread rash, blistering, fever, or signs of infection.

Imikeraderm should not be used by individuals with known hypersensitivity to imiquimod or any formulation components, on broken or infected skin, or by patients with severe immunosuppression unless specifically advised by a physician.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Imiquimod

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT